Peter Brown

Stock price provided by Lang & Schwarz

Showing transactions by Peter Brown in Abbott Laboratories.

Quarter	Type	Shares before	Shares after	Change	Price range
2024-Q2	Buy	837K	1.6M	+726K	€94.34–€104.56
2024-Q1	Buy	87K	837K	+749K	€100.18–€111.68
2023-Q3	Sell	945K	87K	-858K	€90.79–€103.50
2023-Q2	Sell	4.5M	945K	-3.6M	€92.75–€102.50
2023-Q1	Buy	2.8M	4.5M	+1.7M	€89.52–€106.18
2022-Q4	Buy	2.5M	2.8M	+240K	€95.63–€107.94
2022-Q3	Sell	4.2M	2.5M	-1.7M	€99.30–€110.46
2022-Q2	Buy	3.1M	4.2M	+1.1M	€97.78–€113.42
2022-Q1	Buy	1.6M	3.1M	+1.6M	€100.45–€122.40
2021-Q4	Buy	235K	1.6M	+1.3M	€98.84–€125.65
2021-Q3	Sell	365K	235K	-130K	€98.56–€108.95
2021-Q1	Sell	516K	365K	-151K	€88.01–€106.18
2020-Q2	Sell	1.1M	516K	-550K	€70.02–€91.15
2017-Q2	Sell	3.1M	1.1M	-2.1M	€38.46–€44.13
2017-Q1	Buy	3M	3.1M	+144K	€36.61–€43.21
2016-Q4	Buy	657K	3M	+2.3M
2016-Q3	Sell	1.3M	657K	-691K
2015-Q3	Buy	412K	1.3M	+936K
2015-Q1	Sell	859K	412K	-447K
2014-Q4	Buy	145K	859K	+714K
2014-Q3	Sell	1.5M	145K	-1.4M
2014-Q2	Buy	872K	1.5M	+632K

Transactions may be incomplete if the investor has purchased shares of the company before they reached the threshold for reporting set in the Securites Exchange Act or other applicable laws.

← Back to all investors